Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 9509248)

1.

Homocysteine and cardiovascular disease.

Refsum H, Ueland PM, Nygård O, Vollset SE.

Annu Rev Med. 1998;49:31-62. Review.

PMID:
9509248
2.

[Homocysteine--a routine biochemical parameter in cardiovascular diseases?].

Gábor D, Hrnciar J, Hricová I, Zacharová M.

Vnitr Lek. 1999 Jan;45(1):40-5. Slovak.

PMID:
10422525
3.

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M; DACH-LIGA Homocystein e.V.

Clin Chem Lab Med. 2003 Nov;41(11):1392-403. Review. Erratum in: Clin Chem Lab Med. 2004 Jan;42(1):113-6.

PMID:
14656016
4.

Homocysteine and renal disease.

van Guldener C, Robinson K.

Semin Thromb Hemost. 2000;26(3):313-24. Review.

PMID:
11011849
5.
6.

Plasma total homocysteine, folate, and vitamin B12 status in Korean adults.

Lim HS, Heo YR.

J Nutr Sci Vitaminol (Tokyo). 2002 Aug;48(4):290-7.

PMID:
12489820
7.

Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study.

Fakhrzadeh H, Ghotbi S, Pourebrahim R, Nouri M, Heshmat R, Bandarian F, Shafaee A, Larijani B.

BMC Public Health. 2006 Feb 13;6:29.

9.

Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.

Sadeghian S, Fallahi F, Salarifar M, Davoodi G, Mahmoodian M, Fallah N, Darvish S, Karimi A; Tehran Heart Center.

BMC Cardiovasc Disord. 2006 Sep 26;6:38.

10.

Homocysteine and risk of cardiovascular disease.

Andreotti F, Burzotta F, Manzoli A, Robinson K.

J Thromb Thrombolysis. 2000 Jan;9(1):13-21. Review.

PMID:
10590184
11.
12.

[Homocysteine as a coronary risk factor].

Derbeneva SA, Pogozheva AV.

Vopr Pitan. 2003;72(5):43-8. Review. Russian.

PMID:
14619617
13.

Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease.

Mahalle N, Kulkarni MV, Garg MK, Naik SS.

J Cardiol. 2013 Apr;61(4):289-94. doi: 10.1016/j.jjcc.2012.11.009. Epub 2013 Mar 6.

14.

Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.

Billion S, Tribout B, Cadet E, Queinnec C, Rochette J, Wheatley P, Bataille P.

Nephrol Dial Transplant. 2002 Mar;17(3):455-61.

15.

[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].

Sydow K, Böger RH.

Z Kardiol. 2001 Jan;90(1):1-11. Review. German.

PMID:
11220081
16.

Determinants and distributions of plasma total homocysteine concentrations among school children in Taiwan.

Chang JB, Chu NF, Shen MH, Wu DM, Liang YH, Shieh SM.

Eur J Epidemiol. 2003;18(1):33-8.

PMID:
12705621
17.

[Homocysteine. The cardiovascular risk factor of the next millennium?].

Suárez García I, Gómez Cerezo JF, Ríos Blanco JJ, Barbado Hernández FJ, Vázquez Rodríguez JJ.

An Med Interna. 2001 Apr;18(4):211-7. Review. Spanish.

PMID:
11496543
18.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
19.

B vitamins and homocysteine in cardiovascular disease and aging.

Wilcken DE, Wilcken B.

Ann N Y Acad Sci. 1998 Nov 20;854:361-70. Review.

PMID:
9928444
20.

Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.

Hoţoleanu C, Porojan-Iuga M, Rusu ML, Andercou A.

Rom J Intern Med. 2007;45(2):159-64. Review.

PMID:
18333369
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk